Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:25 am Sale | 2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ | BLACK HORSE CAPITAL LP | 0 0.000% | -500,000 (Position Closed) | Filing History |
| 2024-02-06 11:12 am Purchase | 2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 814,383 1.800% | 787,291 (+2905.99%) | Filing History |
| 2023-07-10 5:12 pm Purchase | 2023-06-30 | 13G | Baudax Bio, Inc. BXRXQ | BLACK HORSE CAPITAL LP | 500,000 6.900% | 500,000 (New Position) | Filing History |
| 2023-02-14 12:18 pm Purchase | 2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ | ARMISTICE CAPITAL LLC | 1,165,709 4.990% | 1,165,709 (New Position) | Filing History |
| 2023-02-08 06:06 am Purchase | 2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ | Mitchell P. Kopin | 27,092 5.100% | 27,092 (New Position) | Filing History |
| 2022-09-06 06:13 am Purchase | 2022-08-29 | 13G | Baudax Bio, Inc. BXRX | Mitchell P. Kopin | 27,291 6.500% | 16,697 (+157.60%) | Filing History |
| 2022-05-27 4:03 pm Purchase | 2022-05-17 | 13G | Baudax Bio, Inc. BXRX | Mitchell P. Kopin | 10,595 4.990% | 9,259 (+692.98%) | Filing History |
| 2022-02-14 6:41 pm Purchase | 2021-12-31 | 13G | Baudax Bio, Inc. BXRX | ARMISTICE CAPITAL LLC | 6,335 9.990% | 3,233 (+104.20%) | Filing History |
| 2022-01-06 4:03 pm Purchase | 2021-12-27 | 13G | Baudax Bio, Inc. BXRX | Mitchell P. Kopin | 1,336 2.100% | 1,336 (New Position) | Filing History |
| 2021-02-16 5:08 pm Purchase | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | ARMISTICE CAPITAL LLC | 3,102 9.990% | 2,460 (+382.84%) | Filing History |
| 2021-02-16 3:39 pm Sale | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | CORSAIR CAPITAL MANAGEMENT L.P. | 65 1.000% | -521 (-88.94%) | Filing History |
| 2021-02-16 09:43 am Sale | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | CVI Investments, Inc. | 0 0.000% | -769 (Position Closed) | Filing History |
| 2021-02-12 4:58 pm Sale | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | Stonepine Capital Management LLC | 0 0.000% | -1,300 (Position Closed) | Filing History |
| 2021-01-13 09:01 am Sale | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | Empery Asset Management LP | 714 2.600% | -1,374 (-65.79%) | Filing History |
| 2021-01-07 11:23 am Sale | 2020-12-31 | 13G | Baudax Bio, Inc. BXRX | SABBY MANAGEMENT LLC | 0 0.000% | -744 (Position Closed) | Filing History |
| 2020-10-30 10:30 am Purchase | 2020-10-28 | 13G | Baudax Bio, Inc. BXRX | SABBY MANAGEMENT LLC | 744 11.000% | 744 (New Position) | Filing History |
| 2020-06-09 4:32 pm Sale | 2020-05-31 | 13G | Baudax Bio, Inc. BXRX | BlackRock Inc. BLK | 349 2.800% | -18 (-5.02%) | Filing History |
| 2020-04-03 5:10 pm Purchase | 2020-03-24 | 13G | Baudax Bio, Inc. BXRX | ARMISTICE CAPITAL LLC | 643 4.990% | 643 (New Position) | Filing History |
| 2020-04-02 4:43 pm Purchase | 2020-03-24 | 13G | Baudax Bio, Inc. BXRX | Stonepine Capital Management LLC | 1,300 9.990% | 1,300 (New Position) | Filing History |
| 2020-04-02 09:59 am Purchase | 2020-03-24 | 13G | Baudax Bio, Inc. BXRX | CVI Investments, Inc. | 769 6.300% | 769 (New Position) | Filing History |